Assessment of the Anti-inflammatory Effects of NORFLO® ORO in Acute Relapses of HLA-B27-associated Autoimmune Uveitis: A Multicenter, Randomized, Placebo-controlled, Double-blind Clinical Study.
Pia AllegriCimino LucaJanet L DavisCarl P Herbortnull nullPublished in: Ocular immunology and inflammation (2022)
A beneficial effect of PHBC treatment is suggested because the proportion of responders was significantly higher in this group of patients.
Keyphrases
- double blind
- placebo controlled
- clinical trial
- phase iii
- phase ii
- end stage renal disease
- study protocol
- phase ii study
- chronic kidney disease
- newly diagnosed
- prognostic factors
- randomized controlled trial
- peritoneal dialysis
- drug induced
- liver failure
- open label
- cross sectional
- patient reported outcomes
- ankylosing spondylitis
- combination therapy
- radiation therapy